Last reviewed · How we verify

Intragastric denatonium benzoate — Competitive Intelligence Brief

Intragastric denatonium benzoate (Intragastric denatonium benzoate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bitter taste receptor agonist / Aversive agent. Area: Gastroenterology / Obesity / Safety.

marketed Bitter taste receptor agonist / Aversive agent Bitter taste receptors (T2R family) Gastroenterology / Obesity / Safety Small molecule Live · refreshed every 30 min

Target snapshot

Intragastric denatonium benzoate (Intragastric denatonium benzoate) — Universitaire Ziekenhuizen KU Leuven. Denatonium benzoate is a bitter-tasting compound administered intragastrically that triggers aversive taste responses to discourage accidental ingestion or promote satiety.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Intragastric denatonium benzoate TARGET Intragastric denatonium benzoate Universitaire Ziekenhuizen KU Leuven marketed Bitter taste receptor agonist / Aversive agent Bitter taste receptors (T2R family)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bitter taste receptor agonist / Aversive agent class)

  1. Universitaire Ziekenhuizen KU Leuven · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intragastric denatonium benzoate — Competitive Intelligence Brief. https://druglandscape.com/ci/intragastric-denatonium-benzoate. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: